��

Akero

0 followers

‌

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being eva... Read more

Industries

Education, Biotechnology

Headquarters

South San Francisco, United States

Employees

Links

Org chart

President & CEO

Andrew Cheng

Collapse

COO & Co Founder

Chief Scientific Officer & Co-Founder

CFO & Head of Corporate Development

Chief Development Officer

Dominick Villani

VP & Quality

Brittany de Temple

VP of Development Operations

VP of Regulatory Affairs

SVP, Commercial Strategy

EVP And Chief Development Officer

Vice President Legal

Board Member

Teams

Clinical Research and Development

12 members

Financial and Accounting Team

7 members

Development Team

6 members

Leadership Team

6 members

Quality Control Team

3 members

Similar companies

Colossal Biosciences

2 followers

Tessera Therapeutics

2 followers

MedRhythms

1 follower

Adaptive Biotechnologies

13 followers

SOPHiA GENETICS

4 followers

Thermo Fisher Scientific

168 followers

Genentech

150 followers

Gilead Sciences

129 followers

Biogen

115 followers

Regeneron

95 followers

Vertex Pharmaceuticals

59 followers

Explore companies